Articles by Disease (Transitional Cell Cancer)

MtDNA As a Cancer Marker: A Finally Closed Chapter?

Journal: Current Genomics
Volume: 18
Page: 255-267
Author(s): Elmar Kirches*

Emerging Immunotargets in Bladder Cancer

Journal: Current Drug Targets
Volume: 17
Page: 757-770
Author(s): Francesco Massari, Chiara Ciccarese, Nuno Vau, Matteo Santoni, Rodolfo Montironi, Liang Cheng, Rita C. Marques, Marina Scarpelli, Jorge Fonseca, Marc R Matrana, Moch Holger, Stefano Cascinu, Giampaolo Tortora and Antonio Lopez-Beltran

Advances in Hyaluronic Acid-Based Drug Delivery Systems

Journal: Current Drug Targets
Volume: 17
Page: 720-730
Author(s): Yan Jiao, Xin Pang and Guangxi Zhai

Antagonists of IAP Proteins: Novel Anti-Tumor Agents

Journal: Current Medicinal Chemistry
Volume: 21
Page: 3877-3892
Author(s): Yichao Wan, Tingting Liu, Xuben Hou, Yanyan Dun, Peng Guan and Hao Fang

New Perspective on the Dual Functions of Indirubins in Cancer Therapy and Neuroprotection

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14
Page: 1213-1219
Author(s): Ying Wang, Pui Man Hoi, Judy Yuet-Wa Chan and Simon M.-Y. Lee

The Preclinical Bases of the Rational Combination of Paclitaxel and Antiangiogenic Drugs

Journal: Clinical Cancer Drugs
Volume: 1
Page: 100-115
Author(s): Antonello Di Paolo, Guido Bocci and Romano Danesi

Deregulation of HOX B13 Expression in Urinary Bladder Cancer Progression

Journal: Current Medicinal Chemistry
Volume: 20
Page: 833-839
Author(s): L. Marra, M. Cantile, G. Scognamiglio, L. Marra, S. Perdona, E. La Mantia, M. Cerrone, V. Gigantino, C. Cillo, M. Caraglia, S. Pignata, G. Facchini, G. Botti, S. Chieffi, P. Chieffi and R. Franco